Popular
Continuous Glucose and Ketone Monitoring: Making Smarter Decisions in Diabetes
CME/CEContinuous Glucose and Ketone Monitoring: Making Smarter Decisions in Diabetes
Stephen Brunton, MD, FAAFP, CDCES
James R. Gavin III, MD, PhD
Davida F. Kruger, MSN, APN-BC, BC-ADM
Eden Miller, DO, D-ACD, D-ABOM
INFINITY in Focus: Translating New Nonsteroidal MRA Evidence Into Cardiorenal Practice
NephrologyINFINITY in Focus: Translating New Nonsteroidal MRA Evidence Into Cardiorenal Practice
Peter Rossing, MD, DMSc
Real-World Evidence: Effectiveness of Finerenone in Reducing UACR in Patients With CKD and Type 2 Diabetes
Diabetes and EndocrinologyReal-World Evidence: Effectiveness of Finerenone in Reducing UACR in Patients With CKD and Type 2 Diabetes
Csaba P. Kovesdy, MD
FINE-ONE Across the Ages: Evaluating nsMRA Evidence in CKD and Type 1 Diabetes
Diabetes and EndocrinologyFINE-ONE Across the Ages: Evaluating nsMRA Evidence in CKD and Type 1 Diabetes
Katherine Tuttle, MD
Starting With Confidence: A Practical Framework for Amyloid-Targeting Therapy in Early Alzheimer’s Disease
CME/CEStarting With Confidence: A Practical Framework for Amyloid-Targeting Therapy in Early Alzheimer’s Disease
Dani Cabral, MD
Translating Evidence Into Practice: Myosin Inhibition Across the HCM Spectrum
CME/CETranslating Evidence Into Practice: Myosin Inhibition Across the HCM Spectrum
Christian Schulze, MD, PhD
Ahmad Masri, MD, MS
Michelle Michels, MD
Programs
FINE-ONE Across the Ages: Evaluating nsMRA Evidence in CKD and Type 1 Diabetes
Diabetes and EndocrinologyFINE-ONE Across the Ages: Evaluating nsMRA Evidence in CKD and Type 1 Diabetes
Katherine Tuttle, MD
Treatment Challenges with Chronic Atopic Dermatitis
Practical DermatologyTreatment Challenges with Chronic Atopic Dermatitis
Naiem T. Issa, MD, PhD, FAAD
Maureen N. Offiah, MD, FAAD
Reimagining Alzheimer's Care: The Advent of Subcutaneous Administration of Anti-Amyloid Therapy
CME/CEReimagining Alzheimer's Care: The Advent of Subcutaneous Administration of Anti-Amyloid Therapy
R. Scott Turner, MD, PhD
Engineering Safer Antithrombotic Strategies for Secondary Stroke Prevention
CME/CEEngineering Safer Antithrombotic Strategies for Secondary Stroke Prevention
C. Michael Gibson, MD, MS
Valeria Caso, MD, PhD
Ashkan Shoamanesh, MD
Using Topical Therapies for Pediatric Atopic Dermatitis
Practical DermatologyUsing Topical Therapies for Pediatric Atopic Dermatitis
Naiem T. Issa, MD, PhD, FAAD
Maureen N. Offiah, MD, FAAD
Naiem T. Issa, MD, PhD, FAAD
Maureen N. Offiah, MD, FAAD
Clinical Practice
Pediatric Flu Vaccines: Evidence, Guidelines, and Communication
VacciNationPediatric Flu Vaccines: Evidence, Guidelines, and Communication
Brian P. McDonough, MD, FAAFP
Robert W. Frenck Jr., MD
Continuous Glucose and Ketone Monitoring: Making Smarter Decisions in Diabetes
CME/CEContinuous Glucose and Ketone Monitoring: Making Smarter Decisions in Diabetes
Stephen Brunton, MD, FAAFP, CDCES
James R. Gavin III, MD, PhD
Davida F. Kruger, MSN, APN-BC, BC-ADM
Eden Miller, DO, D-ACD, D-ABOM
Secondary Stroke Prevention in Focus: Addressing Residual Thrombotic Risk
CME/CE Broadcast ReplaySecondary Stroke Prevention in Focus: Addressing Residual Thrombotic Risk
Deborah Kerrigan, MD
Clay Johnston, MD
Oral GLP-1 RA Therapy in Type 2 Diabetes and High Cardiovascular Risk
CME/CEOral GLP-1 RA Therapy in Type 2 Diabetes and High Cardiovascular Risk
Brian P. McDonough, MD, FAAFP
Silvio Inzucchi, MD
Jay H. Shubrook, DO, FACOFP, FAAFP
Personalized CRC Screening: Applying Real-World Evidence to Test Selection
Clinician's RoundtablePersonalized CRC Screening: Applying Real-World Evidence to Test Selection
Brian P. McDonough, MD, FAAFP
David A. Johnson, MD, FACG, FACP
LGMD in Focus: Early Diagnosis, Precision Subtyping, and Targeted Therapies
CME/CELGMD in Focus: Early Diagnosis, Precision Subtyping, and Targeted Therapies
Kaitlin Batley, MD
Peter Karachunski, MD
Doctors Lounge
Brian P. McDonough, MD, FAAFP
Michael Moor, MD, PhD
Earlier Detection, Smarter Prevention: AI-Powered Alzheimer's Care
The ConvergenceEarlier Detection, Smarter Prevention: AI-Powered Alzheimer's Care
Brian P. McDonough, MD, FAAFP
Adrian Noriega de la Colina, MD, PhD
Arvid E. Gollwitzer
“We have the opportunity to understand what happens when someone leaves the clinic,” says Dr. Rajiv Kumar of Apple and Stanford Medicine
The Convergence“We have the opportunity to understand what happens when someone leaves the clinic,” says Dr. Rajiv Kumar of Apple and Stanford Medicine
Brian P. McDonough, MD, FAAFP
Rajiv Kumar, MD
Engaging Patients and Caregivers About Digital Therapeutics
Medical Industry FeatureEngaging Patients and Caregivers About Digital Therapeutics
Charles Turck, PharmD, BCPS, BCCCP
Maggie Emerson, DNP, APRN, PMHNP-BC
Maintaining Weight Loss: Early Evidence on Microbiome-Derived Supplementation
NutritionEdgeMaintaining Weight Loss: Early Evidence on Microbiome-Derived Supplementation
Marlene Mimi Maeusli, PhD.
Hallie Blevins, PhD
Optimizing Medical Affairs Approaches with CME Best Practices
MAPSChatsOptimizing Medical Affairs Approaches with CME Best Practices
Matt Birnholz, MD
Karen Roy, MSc
CME
Starting With Confidence: A Practical Framework for Amyloid-Targeting Therapy in Early Alzheimer’s Disease
CME/CEStarting With Confidence: A Practical Framework for Amyloid-Targeting Therapy in Early Alzheimer’s Disease
Dani Cabral, MD
Navigating the Limitations of Current BD Therapies
MinuteCE®Navigating the Limitations of Current BD Therapies
Jose M. Rubio, MD, PhD
Sunny X. Tang, MD
When “Mild” Matters Most: Closing Clinical Gaps in Early Symptomatic Alzheimer’s Disease
CME/CE Broadcast ReplayWhen “Mild” Matters Most: Closing Clinical Gaps in Early Symptomatic Alzheimer’s Disease
Dani Cabral, MD
David Weisman, MD
Sticking Points: Managing Injection Site Reactions From Long-Acting Injectable Medications for HIV Care
CME/CESticking Points: Managing Injection Site Reactions From Long-Acting Injectable Medications for HIV Care
Dakota Price, MD
Emma Atkinson, PharmD
The Sequencing Puzzle: Integrating Oral SERDs and PROTACs into the mBC Treatment Landscape
MinuteCE®The Sequencing Puzzle: Integrating Oral SERDs and PROTACs into the mBC Treatment Landscape
Komal Jhaveri, MD, FACP
Virginia Kaklamani, MD, DSc
Navigating Treatment Selection After First-line CDK4/6 Inhibitor Progression
MinuteCE®Navigating Treatment Selection After First-line CDK4/6 Inhibitor Progression
Komal Jhaveri, MD, FACP
Virginia Kaklamani, MD, DSc
Industry Feature
Treatment Considerations in Ulcerative Colitis: Shared Decision-Making
Medical Industry FeatureTreatment Considerations in Ulcerative Colitis: Shared Decision-Making
David T. Rubin, MD
Josh Steinberg, MD
Bowel Urgency as a Key Symptom in Ulcerative Colitis
Medical Industry FeatureBowel Urgency as a Key Symptom in Ulcerative Colitis
Ehsan Navabi, MD
Christie Morrison, NP
Bowel Urgency as a Key Symptom in Crohn’s Disease
Medical Industry FeatureBowel Urgency as a Key Symptom in Crohn’s Disease
Partha Nandi, MD
Amy Stewart, CRNP
A Real-World CIDP Patient Journey: Perspectives From a Neuromuscular Specialist
Medical Industry FeatureA Real-World CIDP Patient Journey: Perspectives From a Neuromuscular Specialist
Shiv Bhadola, MD
Understanding Obesity: From Adiposity to Multi-Organ Impact
Medical Industry FeatureUnderstanding Obesity: From Adiposity to Multi-Organ Impact
Robert F. Kushner, MD
Uncovering Metabolic Connections: Obesity, MASLD, and Heart Disease
Medical Industry FeatureUncovering Metabolic Connections: Obesity, MASLD, and Heart Disease
Robert F. Kushner, MD